Go Pro
→ A $382 trillion migration and the position no one is talking about (From Awesomely) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HTGMQ
HTG Molecular Diagnostics
$0.00
$0.00
▼
$0.00
N/A31,989 shsN/A
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
$26.08
$26.08
$14.10
▼
$26.09
$3.24B0.52633,228 shsN/A
Penumbra, Inc. stock logo
PEN
Penumbra
$323.36
-0.3%		$320.38
$221.26
▼
$362.41
$12.74B0.7646,029 shs513,088 shs
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
$0.00
$0.00
▼
$0.00
$1K1.091,024 shsN/A
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HTGMQ
HTG Molecular Diagnostics
0.00%0.00%0.00%0.00%0.00%
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
0.00%0.00%0.00%0.00%0.00%
Penumbra, Inc. stock logo
PEN
Penumbra
+0.27%-0.21%+1.89%+1.21%+22.41%
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
HTGMQ
HTG Molecular Diagnostics
$0.00
$0.00
▼
$0.00
N/A31,989 shsN/A
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
$26.08
$26.08
$14.10
▼
$26.09
$3.24B0.52633,228 shsN/A
Penumbra, Inc. stock logo
PEN
Penumbra
$323.36
-0.3%		$320.38
$221.26
▼
$362.41
$12.74B0.7646,029 shs513,088 shs
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
$0.00
$0.00
▼
$0.00
$1K1.091,024 shsN/A
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
HTGMQ
HTG Molecular Diagnostics
0.00%0.00%0.00%0.00%0.00%
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
0.00%0.00%0.00%0.00%0.00%
Penumbra, Inc. stock logo
PEN
Penumbra
+0.27%-0.21%+1.89%+1.21%+22.41%
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
HTGMQ
HTG Molecular Diagnostics
0.00
N/AN/AN/A
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
0.00
N/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
2.18
Hold$367.0713.52% Upside
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest OLK, THMO, HTGMQ, and PEN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/24/2026
Penumbra, Inc. stock logo
PEN
Penumbra
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
7/17/2026
Penumbra, Inc. stock logo
PEN
Penumbra
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
7/6/2026
Penumbra, Inc. stock logo
PEN
Penumbra
Evercore Inc logo
Evercore
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$320.00
6/29/2026
Penumbra, Inc. stock logo
PEN
Penumbra
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
6/11/2026
Penumbra, Inc. stock logo
PEN
Penumbra
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSector Perform$374.00
(Data available from 8/26/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
HTGMQ
HTG Molecular Diagnostics
$6.37M0.00N/AN/AN/ANaN
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
$170.89M18.98N/AN/A$4.04 per share6.46
Penumbra, Inc. stock logo
PEN
Penumbra
$1.40B9.07$4.29 per share75.31$38.86 per share8.32
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
$9.61M0.00N/AN/A($0.99) per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
HTGMQ
HTG Molecular Diagnostics
-$21.59MN/AN/AN/AN/AN/AN/AN/AN/A
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
-$31.60M-$0.27N/A1,304.00N/A-19.72%-7.07%-6.05%N/A
Penumbra, Inc. stock logo
PEN
Penumbra
$177.69M$4.0779.4552.072.0110.67%10.50%8.17%11/4/2026 (Estimated)
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
-$17.98M-$5.14N/AN/AN/AN/AN/AN/AN/A

Latest OLK, THMO, HTGMQ, and PEN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2026Q2 2026
Penumbra, Inc. stock logo
PEN
Penumbra
$1.16$0.88-$0.28$0.88$389.64 million$390.05 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/AN/A
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/A
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
N/A
5.60
3.91
Penumbra, Inc. stock logo
PEN
Penumbra
0.01
5.75
3.86
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
HTGMQ
HTG Molecular Diagnostics
N/A
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
30.19%
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
5.78%

Insider Ownership

CompanyInsider Ownership
HTGMQ
HTG Molecular Diagnostics
2.60%
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
5.20%
Penumbra, Inc. stock logo
PEN
Penumbra
2.90%
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
78.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
HTGMQ
HTG Molecular Diagnostics
90630,0002.16 millionNot Optionable
Olink Holding AB (publ) stock logo
OLK
Olink Holding AB (publ)
420124.34 million117.88 millionNo Data
Penumbra, Inc. stock logo
PEN
Penumbra
4,70039.39 million38.25 millionOptionable
ThermoGenesis Holdings, Inc. stock logo
THMO
ThermoGenesis
407.95 million1.75 millionNot Optionable

Recent News About These Companies

ThermoGenesis Holdings Inc.
July 27, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/thmo/financials
CitrusBurn Analyzed (INSIDER REPORT) Does Citrus Burn Natural Weight Loss Supplement Really Work? Achieves 74% Thermogenesis Increase in Clinical Studies
February 19, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/02/19/3241422/0/en/citrusburn-analyzed-insider-report-does-citrus-burn-natural-weight-loss-supplement-really-work-achieves-74-thermogenesis-increase-in-clinical-studies.html
THMO | ThermoGenesis Holdings Inc. Annual Cash Flow Statement | MarketWatch
July 29, 2025  |  marketwatch.comhttps://www.marketwatch.com/investing/stock/thmo/financials/cash-flow
The Ice Water Hack: How Aqua Sculpt Boosts Thermogenesis for Fat Loss
March 10, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/03/10/3039487/0/en/the-ice-water-hack-how-aqua-sculpt-boosts-thermogenesis-for-fat-loss.html
Ice Water Hack: How Aqua Sculpt Improves Thermogenesis for Weight Loss
February 20, 2025  |  globenewswire.comhttps://www.globenewswire.com/news-release/2025/02/20/3029625/0/en/ice-water-hack-how-aqua-sculpt-improves-thermogenesis-for-weight-loss.html
North American Morning Briefing: Stock Futures, -2-
September 19, 2024  |  morningstar.comM
Is Thermogenesis Holdings Inc Stock (THMO) a Good Investment?
August 8, 2024  |  aaii.comA
ThermoGenesis Holdings (OTC:THMO) Stock Quotes, Forecast and News Summary
July 28, 2024  |  benzinga.comhttps://www.benzinga.com/quote/THMO
ThermoGenesis Holdings (OTC:THMO) Stock, Short Interest Report
July 28, 2024  |  benzinga.comhttps://www.benzinga.com/quote/THMO/short-interest
Why Is ThermoGenesis (THMO) Stock Down 37% Today?
June 12, 2024  |  investorplace.comhttps://investorplace.com/2024/06/why-is-thermogenesis-thmo-stock-down-37-today/
THMO Stock Earnings: ThermoGenesis Holdings Misses EPS, Misses Revenue for Q1 2024
May 17, 2024  |  investorplace.comhttps://investorplace.com/earning-results/2024/05/thmo-stock-earnings-thermogenesis-holdings-for-q1-of-2024/?cc=marketbeat&cp=pdtk
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Is About To Turn The Corner
February 27, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/thermogenesis-holdings-inc-nasdaq-thmo-111508436.html?.tsrc=rss
ThermoGenesis Holdings, Inc.
January 9, 2024  |  thestreet.comhttps://www.thestreet.com/quote/THMO
ThermoGenesis Holdings Stock (NASDAQ:THMO) Dividends: History, Yield and Dates
December 16, 2023  |  benzinga.comhttps://www.benzinga.com/quote/THMO/dividend
Shareholders Will Probably Hold Off On Increasing ThermoGenesis Holdings, Inc.'s (NASDAQ:THMO) CEO Compensation For The Time Being
December 8, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/shareholders-probably-hold-off-increasing-100950163.html?.tsrc=rss
ThermoGenesis Holdings Recent Insider Activity
November 21, 2023  |  benzinga.comhttps://www.benzinga.com/news/23/11/35896638/thermogenesis-holdings-recent-insider-activity
ThermoGenesis Holdings, Inc.: ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
November 15, 2023  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2023-11/60655064-thermogenesis-holdings-inc-thermogenesis-holdings-announces-third-quarter-2023-financial-results-and-provides-corporate-update-008.htm
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q3 2023 Earnings Call Transcript
November 14, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/thermogenesis-holdings-inc-nasdaq-thmo-152609944.html?.tsrc=rss
ThermoGenesis Holdings Announces Third Quarter 2023 Financial Results and Provides Corporate Update
November 13, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/thermogenesis-holdings-announces-third-quarter-210500777.html?.tsrc=rss
ThermoGenesis Q3 Earnings Preview
November 12, 2023  |  msn.comhttps://www.msn.com/en-us/money/savingandinvesting/thermogenesis-q3-earnings-preview/ar-AA1jOtWr

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
SpaceX logo beside a rocket on a launch pad at sunset, with a colorful sky in the background.
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
Laboratory with a cryogenic quantum processor chamber, optical laser setup on a table, and data monitors displaying waveforms.
Quantum Earnings Week: Winners and Losers Are Finally Emerging
By Nathan Reiff | August 8, 2026
SoundHound AI logo displayed within a glowing orange ring against a dark background with light wave effects.
SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
By Thomas Hughes | August 10, 2026
Microsoft logo displayed on a wall-mounted plaque in a modern office lobby with glass partitions.
Microsoft Just Flipped the AI Spending Narrative Overnight
By Chris Markoch | July 30, 2026
Military drone aircraft flying over a mountainous desert landscape at sunset.
3 Drone Stocks That Should Soar After the Summer Slump
By Chris Markoch | August 4, 2026

HTG Molecular Diagnostics NASDAQ:HTGMQ

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Olink Holding AB (publ) stock logo

Olink Holding AB (publ) NASDAQ:OLK

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and data analysis and bioinformatics services. In addition, the company offers Olink normalized protein expression (NPX) data processing software, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in Sweden, the United States, rest of the Americas, rest of Europe, the Middle East, Africa, Japan, and internationally. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. Olink Holding AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.

Penumbra stock logo

Penumbra NYSE:PEN

$323.36 -1.01 (-0.31%)
As of 03:58 PM Eastern

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

ThermoGenesis stock logo

ThermoGenesis NASDAQ:THMO

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, Vietnam, and internationally. The company provides medical device products for automated cell processing. Its clinical bio-banking applications include AXP II Automated Cell Separation System, an automated fully closed cell separation system for isolating stem and progenitor cells from umbilical cord blood; and BioArchive Automated Cryopreservation System, an automated, robotic, liquid nitrogen controlled-rate-freezing and cryogenic storage system for cord blood samples and cell therapeutic products used in clinical applications. The company's point-of-care applications include XP Point-of-Care System, an automated, fully closed, sterile system that allows for the rapid and automated processing of autologous peripheral blood or bone marrow aspirate derived stem cells at the point-of-care, such as surgical centers or clinics; and PXP-1000 System, an automated, fully closed system that provides fast, reproducible separation of multiple cellular components from blood with minimal red blood cell contamination. Its cell processing products comprise X-Series products for general laboratory use, such as X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The company also provides contract development and manufacturing services for cell and cell-based gene therapies. It markets and sells its medical device products through independent distributors, as well as direct to end-user customers. The company was formerly known as Cesca Therapeutics Inc. and changed its name to ThermoGenesis Holdings, Inc. in November 2019. ThermoGenesis Holdings, Inc. was incorporated in 1986 and is headquartered in Rancho Cordova, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas